Literature DB >> 11861492

Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes.

R Rasolonjanahary1, C Gerard, M N Dufour, V Homburger, A Enjalbert, G Guillon.   

Abstract

Dopamine (DA) is known to inhibit basal and hormone TRH- or angiotensin II (AngII)-stimulated PRL secretion and inositol phosphate accumulation in rat pituitary cells in primary culture. This inhibition persists when cells are incubated in a calcium-free medium (a condition in which DA could not inhibit PLC activities by blocking calcium influx) and is abolished by a Pertussis toxin treatment. These data suggest that DA receptor could be negatively coupled to PLC by a direct mechanism involving a Pertussis toxin-sensitive G protein. To demonstrate this hypothesis, we measured PLC activities on crude plasma membranes obtained from rat pituitary cells in primary culture grown in the presence of tritiated myo-inositol. We showed that 1) DA and quinpirole or RU24926 (specific D2 agonists) inhibited both basal and TRH- or AngII-stimulated membrane PLC activities. 2) Such inhibitions were completely prevented by sulpiride (specific D2 antagonist). 3) Heterotrimeric Gi1/2 proteins coupled the DA receptors to PLC because DA inhibitions were completely reversed by preincubation either with Pertussis toxin or with a specific G(alpha)i1/(alpha)i2 antibody. Such data are in favor of the existence of a direct negative coupling between DA-D2 receptor and PLC on a native physiological plasma membrane model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861492     DOI: 10.1210/endo.143.3.8697

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling.

Authors:  Margarita Arango-Lievano; Ozge Sensoy; Amélie Borie; Maithé Corbani; Gilles Guillon; Pierre Sokoloff; Harel Weinstein; Freddy Jeanneteau
Journal:  Mol Cell Biol       Date:  2016-01-19       Impact factor: 4.272

3.  D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Ho-Joo Lee; Richard P Bazinet; Ruth Seemann; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

4.  Dietary sodium modulates the interaction between efferent and afferent renal nerve activity by altering activation of α2-adrenoceptors on renal sensory nerves.

Authors:  Ulla C Kopp; Michael Z Cicha; Lori A Smith; Saku Ruohonen; Mika Scheinin; Nicolas Fritz; Tomas Hökfelt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-24       Impact factor: 3.619

Review 5.  Dopamine resistance of prolactinomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface.

Authors:  Meredith A Hannan; Nadine Kabbani; Constantinos D Paspalas; Robert Levenson
Journal:  Biochim Biophys Acta       Date:  2008-01-18

7.  Spontaneous reduction of prolactinoma post cabergoline withdrawal.

Authors:  Sampath Kumar Venkatesh; Deepak Kothari; Smita Manchanda; Anil Taneja; Bindu Kulshreshtha
Journal:  Indian J Endocrinol Metab       Date:  2012-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.